ASCO GU 2018 Press

Viewing 1-7 of 7 articles

Interim Phase II Safety and Efficacy Data for SM-88 in Prostate Cancer Announced at 2018 ASCO Genitourinary Cancers Symposium

Bayer to Feature Prostate Cancer Research at ASCO GU 2018 Symposium

Apalutamide Delays Prostate Cancer Metastases by More Than Two Years

New Model Predicts Survival for People with Bladder Cancer Receiving Immunotherapy

Adding Immunotherapy to Standard Treatment Slows Growth of Advanced Kidney Cancer, with Fewer Side Effects

Chemotherapy Added to Hormone Therapy for Prostate Cancer Improves Quality of Life

The 2018 Genitourinary Cancers Symposium (ASCO GU 2018) will Feature Insights for Management of Prostate, Bladder and Kidney Cancers